There were 1,796 press releases posted in the last 24 hours and 254,000 in the last 365 days.


Please use this form to send email to PR contact of this press release:
Soligenix, Inc. (NASDAQ: SNGX) Developing Treatments for Multiple Cancers, Vaccine Candidates (Ebola, Sudan, & Marburg)

Soligenix, Inc.
+1 609-538-8200


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image